SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Jun 15, 2016
AGENUS INC (AGEN) (CIK 0001098972)
Date: June 15, 2016 · CIK: 0001098972 · Accession: 0000000000-16-080613
AI Filing Summary & Sentiment
Show Raw Text
June 1 5, 2016 Garo H. Armen Chief Executive Officer Agenus Inc. 3 Forbes Road Lexington, MA 02421 Re: Agenus Inc. Preliminary Proxy Statement on Schedule 14A Filed April 15, 2016 File No. 000 -29089 Dear Mr. Armen : We completed our review of your filing on April 26, 2016. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Mary Beth Breslin for Suzanne Haye s Assistant Director Office of Healthcare and Insurance cc: Zachary R. Blume Ropes & Gray LLP